KLK3 and pachyonychia congenita: However, a growing number of studies have shown that the TNM stage alone does not accurately predict patient outcomes because of multiple factors clinically associated with PC prognosis (4–6), especially the Gleason score(GS) and prostate-specific antigen (PSA).